시장보고서

상품코드

1477100

세계의 약물 용출 코팅 시장 : 유형별, 용도별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율 및 예측(2024-2032년)

Drug-Eluting Coating Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 04월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 289 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

약물 용출 코팅 시장 규모는 2023년 27억 8,934만 달러로 평가되었고, 2024년부터 2032년까지 연평균 8.7% 성장할 것으로 예상됩니다.

약물 용출 코팅 시장 - 시장 역학

저침습 수술에 대한 수요 증가가 시장 성장을 주도하고 있습니다.

약물 용출 스텐트와 작은 절개를 통해 관상동맥의 협착과 막힘을 치료하는 최소침습수술에 대한 수요가 증가함에 따라 시장 확대가 예상됩니다. 예를 들어, 2023년 1월 미국 국립의학도서관은 미국에서 매년 시행되는 최소침습수술 건수가 300만 건을 넘어섰다는 논문을 발표하기도 했습니다. 이러한 수술은 신체적 외상이 적고, 회복이 빠르며, 입원 기간이 짧고, 문제가 적다는 등 여러 가지 장점이 있습니다. 그 결과, 최소침습 수술에 대한 수요가 증가함에 따라 약물 용출 스텐트 시장 개척이 기대되고 있습니다.

약물 용출 코팅 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 8.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

유형별로는 약물 전달 코팅이 예측 기간 동안 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.

용도별로는 병원 분야가 예측 기간 동안 시장을 독점할 것으로 예상됩니다.

지역별로는 북미가 예측 기간 동안 시장을 독점할 것으로 예상됩니다.

약물 용출 코팅 시장 - 세분화 분석 :

약물 용출 코팅 세계 시장은 유형, 용도 및 지역에 따라 세분화됩니다.

유형별로는 약물 전달 코팅, 생체 적합성 코팅, 폴리머 프리 코팅/표면으로 구분됩니다. 약물 전달 코팅 부문은 예측 기간 동안 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 이 부문 증가는 만성 질환의 유병률 증가에 기인합니다. 당뇨병, 암, 심혈관 질환과 같은 만성 질환의 세계 부담이 증가함에 따라 약물 용출 코팅이 적용된 혁신적인 의료기기의 인기가 높아지고 있습니다. 이러한 의료기기는 환자의 삶의 질과 치료 결과를 개선하는 것을 목표로 하고 있습니다.

약물 용출 코팅 세계 시장은 용도에 따라 연구소와 병원으로 구분됩니다. 예측 기간 동안 병원 부문이 시장을 주도할 것으로 예상됩니다. 최소 침습 수술에 대한 수요 증가가 이 부문의 성장을 주도하고 있습니다.

약물 용출 코팅 시장 - 지리적 통찰력

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카으로 나뉩니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다. 예측 기간 동안 북미가 시장을 지배할 것으로 예상됩니다. 잘 구축된 의료 인프라의 존재와 약물 용출 스텐트 기술 개발도 시장 확대의 원동력이 되고 있습니다. 예를 들어, 2023년 2월에 발표된 Journal of the American College of Cardiology에 따르면, 미국 내 죽상동맥경화성 심혈관질환 발병률은 10년 예측 위험도가 증가한 사람은 1,000명당 2.60명, 10년 예측 위험도는 낮지만 30년 예측 위험도가 증가한 사람은 2.60명입니다. 낮지만 30년 예측위험이 상승한 사람에서는 1.87명, 10년 예측위험과 30년 예측위험이 낮은 사람에서는 0.32명이었습니다. 그 결과, 죽상동맥경화성 심혈관질환의 유병률 증가로 인해 약물용출 스텐트 치료의 필요성이 높아져 지역 시장 확대가 가속화되고 있는 것으로 분석됐습니다.

약물 용출 코팅 시장 - 경쟁 구도:

시장에서 활동하는 주요 기업으로는 Covalon Technologies Ltd., Carmeda AB, AST Products, Inc, Biophan Technologies, Inc, Biocoat, Inc, Hemoteq AG, Armoloy of Connecticut, Inc., Nanocopoeia, Inc., Hydromer, Inc. 등이 있습니다. 이들 기업은 제품 출시, 인수, 제휴 등 다양한 전략을 통해 이 업계에서 큰 점유율을 차지하기 위해 노력하고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제10장 주요 벤더 분석 - 약물 용출 코팅 업계

경쟁 대시보드
기업 개요
- Covalon Technologies Ltd.
- Carmeda AB
- AST Products, Inc.
- Biophan Technologies, Inc.
- Biocoat, Inc.
- Hemoteq AG
- Armoloy of Connecticut, Inc.
- Nanocopoeia, Inc.
- Hydromer, Inc.
- N2 Biomedical

제11장 애널리스트의 전방위 전망

LSH 24.05.28

REPORT HIGHLIGHT

Drug-Eluting Coating Market size was valued at USD 2,789.34 Million in 2023, expanding at a CAGR of 8.7% from 2024 to 2032.

When a particular layer is placed on medical equipment, such as implants or stents, it's called a drug-eluting coating. Its purpose is to release medication gradually. These coatings can promote healing, lessen inflammation, stop infection, or stop the growth of scar tissue, among other functions. These coatings can lower the risk of problems and increase the efficacy of the device by releasing medications gradually at the site of implantation. The medications used and the coating's formulation is based on the particular medical application and the intended therapeutic results.

Drug-Eluting Coating Market- Market Dynamics

Increasing demand for minimally invasive surgeries drives market growth

The market is anticipated to rise due to the increasing demand for minimally invasive operations, which repair restricted or blocked coronary arteries by employing drug-eluting stents and small incisions. In January 2023, for instance, the National Library of Medicine issued an article stating that the number of cases of minimally invasive surgery performed in the US each year exceeded three million. These operations have several benefits, including less physical trauma, quicker recovery periods, shorter hospital stays, and fewer problems. As a result, the market for drug-eluting stents is expected to develop due to the increased demand for minimally invasive procedures.

Drug-Eluting Coating Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.7% over the forecast period (2024-2032)

Based on type segmentation, the Drug-delivery Coatings segment is expected to capture the largest revenue share over the projected period

Based on application segmentation, the hospital segment is expected to dominate the market over the projected period

Based on region, North America is expected to dominate the market over the forecast period

Drug-Eluting Coating Market- Segmentation Analysis:

The Global Drug-Eluting Coating Market is segmented based on Type, Application and Region.

Based on the type, the Drug-Eluting Coating market is bifurcated into Drug-delivery Coatings, Biocompatible Coatings and Polymer-free Coatings/Surfaces. The Drug-delivery Coatings segment is expected to capture the largest revenue share over the projected period. The segment increase is owing to the rising prevalence of chronic disease. Innovative medical devices with drug-eluting coatings are in increasing popularity as the worldwide burden of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, rises. These devices aim to improve patient quality of life and treatment outcomes.

Based on the application, the global Drug-Eluting Coating market is segmented into Research Institute and Hospital. The Hospital segment is expected to dominate the market over the projected period. The growing demand for minimally invasive surgery driving the segment growth.

Drug-Eluting Coating Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The existence of well-established healthcare infrastructure and technological developments in drug-eluting stents are also driving the market's expansion. For example, the incidence rate of atherosclerotic cardiovascular disease was 2.60 per 1,000 person-years among those with a raised 10-year predicted risk, 1.87 in those with a low 10-year but elevated 30-year predicted risk, and 0.32 in those with low 10-year and 30-year predicted risk in the United States, according to the Journal of the American College of Cardiology published in February 2023. As a result, the increased prevalence of atherosclerotic cardiovascular disease raises the need for drug-eluting stent therapy, which propels regional market expansion.

Drug-Eluting Coating Market- Competitive Landscape:

The key players operating in the market are Covalon Technologies Ltd., Carmeda AB, AST Products, Inc., Biophan Technologies, Inc., Biocoat, Inc., Hemoteq AG, Armoloy of Connecticut, Inc., Nanocopoeia, Inc., Hydromer, Inc. and N2 Biomedical. These players adopted various strategies to gain major market share in the industry including product launches, acquisitions, collaboration and others.

Recent Development:

In June 2023, The FDA in the United States approved the SurVeilTM drug-coated balloon (DCB). Surmodics, Inc. is a prominent supplier of medical devices and in vitro diagnostic technologies to the healthcare sector.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL Drug-Eluting Coating MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Covalon Technologies Ltd.

Carmeda AB

AST Products, Inc.

Biophan Technologies, Inc.

Biocoat, Inc.

Hemoteq AG

Armoloy of Connecticut, Inc.

Nanocopoeia, Inc.

Hydromer, Inc.

N2 Biomedical

GLOBAL Drug-Eluting Coating MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Drug-delivery Coatings
Biocompatible Coatings
Polymer-free Coatings/Surfaces

GLOBAL Drug-Eluting Coating MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Research Institute
Hospital

GLOBAL Drug-Eluting Coating MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Drug-Eluting Coating Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Drug-Eluting Coating Market Snippet by Type
- 2.1.2.Drug-Eluting Coating Market Snippet by Application
- 2.1.3.Drug-Eluting Coating Market Snippet by Country
- 2.1.4.Drug-Eluting Coating Market Snippet by Region
2.2.Competitive Insights

3.Drug-Eluting Coating Key Market Trends

3.1.Drug-Eluting Coating Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Drug-Eluting Coating Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Drug-Eluting Coating Market Opportunities
3.4.Drug-Eluting Coating Market Future Trends

4.Drug-Eluting Coating Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Drug-Eluting Coating Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Drug-Eluting Coating Market Landscape

6.1.Drug-Eluting Coating Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Drug-Eluting Coating Market - By Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2.Drug-delivery Coatings
- 7.1.3.Biocompatible Coatings
- 7.1.4.Polymer-free Coatings/Surfaces

8.Drug-Eluting Coating Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2.Research Institute
- 8.1.3.Hospital

9.Drug-Eluting Coating Market- By Geography

9.1.Introduction
- 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2.North America
- 9.2.1.Overview
- 9.2.2.Drug-Eluting Coating Key Manufacturers in North America
- 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.2.6.U.S.
  - 9.2.6.1.Overview
  - 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.2.7.Canada
  - 9.2.7.1.Overview
  - 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.Europe
- 9.3.1.Overview
- 9.3.2.Drug-Eluting Coating Key Manufacturers in Europe
- 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.6.Germany
  - 9.3.6.1.Overview
  - 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.7.Italy
  - 9.3.7.1.Overview
  - 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.8.United Kingdom
  - 9.3.8.1.Overview
  - 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.9.France
  - 9.3.9.1.Overview
  - 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.10.Russia
  - 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.11.Netherlands
  - 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.12.Sweden
  - 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.13.Poland
  - 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.14.Rest of Europe
  - 9.3.14.1.Overview
  - 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.Asia Pacific (APAC)
- 9.4.1.Overview
- 9.4.2.Drug-Eluting Coating Key Manufacturers in Asia Pacific
- 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.6.India
  - 9.4.6.1.Overview
  - 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.7.China
  - 9.4.7.1.Overview
  - 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.8.Japan
  - 9.4.8.1.Overview
  - 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.9.South Korea
  - 9.4.9.1.Overview
  - 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.10.Australia
  - 9.4.10.1.Overview
  - 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.11.Thailand
  - 9.4.11.1.Overview
  - 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.12.Indonesia
  - 9.4.12.1.Overview
  - 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.13.Philippines
  - 9.4.13.1.Overview
  - 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.14.Rest of APAC
  - 9.4.14.1.Overview
  - 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.5.Latin America
- 9.5.1.Overview
- 9.5.2.Drug-Eluting Coating Key Manufacturers in Latin America
- 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.6.Brazil
  - 9.5.6.1.Overview
  - 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.7.Mexico
  - 9.5.7.1.Overview
  - 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.8.Argentina
  - 9.5.8.1.Overview
  - 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.9.Colombia
  - 9.5.9.1.Overview
  - 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.10.Rest of LATAM
  - 9.5.10.1.Overview
  - 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.Middle East and Africa
- 9.6.1.Overview
- 9.6.2.Drug-Eluting Coating Key Manufacturers in Middle East and Africa
- 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.6.Saudi Arabia
  - 9.6.6.1.Overview
  - 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.7.United Arab Emirates
  - 9.6.7.1.Overview
  - 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.8.Israel
  - 9.6.8.1.Overview
  - 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.9.Turkey
  - 9.6.9.1.Overview
  - 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.10.Algeria
  - 9.6.10.1.Overview
  - 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.11.Egypt
  - 9.6.11.1.Overview
  - 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.12.Rest of MEA
  - 9.6.12.1.Overview
  - 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Drug-Eluting Coating Industry

10.1.Competitive Dashboard
10.2.Company Profiles
- 10.2.1.Covalon Technologies Ltd.
- 10.2.2.Carmeda AB
- 10.2.3.AST Products, Inc.
- 10.2.4.Biophan Technologies, Inc.
- 10.2.5.Biocoat, Inc.
- 10.2.6.Hemoteq AG
- 10.2.7.Armoloy of Connecticut, Inc.
- 10.2.8.Nanocopoeia, Inc.
- 10.2.9.Hydromer, Inc.
- 10.2.10.N2 Biomedical

11.360 Degree Analyst View

12.Appendix

12.1.Research Methodology
12.2.References
12.3.Abbreviations
12.4.Disclaimer
12.5.Contact Us